AU Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals Ltd

Watchlist
  • 27.080
  • -0.040-0.15%
20min DelayNot Open Feb 14 16:00 AET
9.06BMarket Cap1692.50P/E (Static)

Telix Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telix Pharmaceuticals Ltd FY2024 Estimates Date

Currency：AUDFeb 20, 2025

Estimate YoY
Revenue
784.16M
+56.04%
EPS
0.17
+971.43%
Analyst Rating
Buy

Feb 4, 2025

Telix Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 23, 20232023/Q2120.700M / ----
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----
DatePeriodRevenue/EstimateEarnings Call
Aug 23, 20232023/Q2120.700M / ----
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----
--------
--------

Unlock Free Earnings Estimates

Telix Pharmaceuticals Ltd Earnings Reports

  • Telix Pharmaceuticals Ltd: Telix 2024 Full Year Results and Investor Webcast/Call

    Feb 10 16:17 ET

  • Telix Pharmaceuticals Ltd: Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

    Jan 13 01:10 ET

  • Telix Pharmaceuticals Ltd: Telix Q3 2024 Revenue and Business Update

    Oct 17, 2024 02:08 ET

  • Telix Pharmaceuticals Ltd: Telix 1H 2024 Results Presentation

    Aug 22, 2024 02:42 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Origin Energy Ltd
    ORG
    4.60% 0.48
    Rio Tinto Ltd
    RIO
    5.25% 6.36
    Telstra Group Ltd
    TLS
    4.50% 0.18
    Westpac Banking Corp
    WBC
    4.24% 1.47
    ANZ Group Holdings Ltd
    ANZ
    5.66% 1.77

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 4, 2025

    Buy

    • Strong Buy

      77.78%

    • Buy

      0.00%

    • Hold

      11.11%

    • Underperform

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday+0.95%